These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10536248)

  • 1. Influence of the technological parameters of ultrasonic nebulisation on the nebulisation quality of alpha1 protease inhibitor (alpha1PI).
    Flament MP; Leterme P; Gayot A
    Int J Pharm; 1999 Nov; 189(2):197-204. PubMed ID: 10536248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the technological parameters of ultrasonic nebulization.
    Flament MP; Leterme P; Gayot A
    Drug Dev Ind Pharm; 2001 Aug; 27(7):643-9. PubMed ID: 11694011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of formulation on jet nebulisation quality of alpha 1 protease inhibitor.
    Flament MP; Leterme P; Burnouf T; Gayot A
    Int J Pharm; 1999 Feb; 178(1):101-9. PubMed ID: 10205630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers.
    Najlah M; Parveen I; Alhnan MA; Ahmed W; Faheem A; Phoenix DA; Taylor KM; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):234-41. PubMed ID: 24275450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes.
    Birchall JC; Kellaway IW; Gumbleton M
    Int J Pharm; 2000 Mar; 197(1-2):221-31. PubMed ID: 10704809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance.
    Chan JG; Kwok PC; Young PM; Chan HK; Traini D
    J Pharm Sci; 2011 Jul; 100(7):2693-702. PubMed ID: 21283985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition.
    Dijk PH; Heikamp A; Piers DA; Weller E; Bambang Oetomo S
    Intensive Care Med; 1997 Apr; 23(4):456-62. PubMed ID: 9142589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system.
    Votion D; Ghafir Y; Munsters K; Duvivier DH; Art T; Lekeux P
    Equine Vet J; 1997 Sep; 29(5):388-93. PubMed ID: 9306067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation.
    Harvey CJ; O'Doherty MJ; Page CJ; Thomas SH; Nunan TO; Treacher DF
    Thorax; 1995 Jan; 50(1):50-3. PubMed ID: 7886649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization by isotope method of the performance of the pneumatic nebulizer NL9 Atomizer in the production of colistin, tobramycin and amiloride aerosols].
    Diot P; Le Pape A; Boissinot E; Lemarié E
    Rev Mal Respir; 1994; 11(6):573-8. PubMed ID: 7831507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo deposition study of a new generation nebuliser utilising hybrid resonant acoustic (HYDRA) technology.
    Kwok PCL; McDonnell A; Tang P; Knight C; McKay E; Butler SP; Sivarajah A; Quinn R; Fincher L; Browne E; Yeo LY; Chan HK
    Int J Pharm; 2020 Apr; 580():119196. PubMed ID: 32145340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets.
    Berg E; Lamb P; Ali A; Dennis J; Tservistas M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):21-5. PubMed ID: 18430403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics.
    Hung JC; Hambleton G; Super M
    Arch Dis Child; 1994 Oct; 71(4):335-8. PubMed ID: 7979528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced delivery of nebulised salbutamol during non-invasive ventilation.
    Calvert LD; Jackson JM; White JA; Barry PW; Kinnear WJ; O'Callaghan C
    J Pharm Pharmacol; 2006 Nov; 58(11):1553-7. PubMed ID: 17132219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of jet nebulisers for use with gentamicin solution.
    Newman SP; Pellow PG; Clay MM; Clarke SW
    Thorax; 1985 Sep; 40(9):671-6. PubMed ID: 4060108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical model of some aspects of jet nebuliser performance.
    Smye SW; Jollie MI; Littlewood JM
    Clin Phys Physiol Meas; 1991 Aug; 12(3):289-300. PubMed ID: 1934916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
    Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.
    Dennis JH; Stenton SC; Beach JR; Avery AJ; Walters EH; Hendrick DJ
    Thorax; 1990 Oct; 45(10):728-32. PubMed ID: 2247862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stability of inhaled drugs as a requisite for safe therapy as for example, with nebulised glucocorticosteroids].
    Alkiewicz J; Szczawińska-Popłonyk A; Makowska M
    Pneumonol Alergol Pol; 1997; 65 Suppl 1():7-17. PubMed ID: 9410305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolization potential of cyclodextrins--influence of the operating conditions.
    Le VN; Leterme P; Gayot A; Flament MP
    PDA J Pharm Sci Technol; 2006; 60(5):314-22. PubMed ID: 17089700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.